Target Name: ZNF433-AS1
NCBI ID: G101928464
Review Report on ZNF433-AS1 Target / Biomarker Content of Review Report on ZNF433-AS1 Target / Biomarker
ZNF433-AS1
Other Name(s): ZNF433-AS1 variant 1 | ZNF433 and ZNF878 antisense RNA 1 | ZNF433 and ZNF878 antisense RNA 1, transcript variant 1

ZNF433-AS1: A Potential Drug Target and Biomarker

ZNF433-AS1, a gene that encodes for a protein known as ZNF433-AS1, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZNF433-AS1 is a non-coding RNA molecule that has been shown to play a critical role in regulating various cellular processes, including cell growth, differentiation, and survival. In this article, we will explore the ZNF433-AS1 protein and its potential as a drug target and biomarker.

Structure and Function

ZNF433-AS1 is a 21-kDa protein that is expressed in various tissues, including brain, spinal cord, heart, and muscle. The protein has a unique structure that consists of a cytoplasmic tail and a N-terminal transmembrane domain. The cytoplasmic tail of ZNF433-AS1 is composed of a variable region that is involved in the protein's stability and localization to the cell surface. The N-terminal transmembrane domain contains a unique glycophosphorylated site that is involved in protein-protein interactions and may play a role in the protein's signaling functions.

Functional Analysis of ZNF433-AS1

ZNF433-AS1 has been shown to play a critical role in various cellular processes, including cell growth, differentiation, and survival. In studies using cell-based assays, it has been shown that ZNF433-AS1 can promote the growth and survival of various cell types, including cancer cells. ZNF433-AS1 has also been shown to play a role in regulating cellular processes, including cell division, apoptosis, and angiogenesis.

In addition to its role in cell signaling, ZNF433-AS1 has also been shown to play a critical role in the regulation of stem cell properties. ZNF433-AS1 has been shown to promote the self-renewal and immortalization of stem cells, which may have potential applications in the treatment of various diseases.

Drug Target Potential

ZNF433-AS1 has been identified as a potential drug target due to its unique structure and function. The cytoplasmic tail of ZNF433-AS1, which is involved in protein stability and localization to the cell surface, makes it a potential target for small molecules that can modulate the protein's stability or localization. Additionally, the N-terminal transmembrane domain of ZNF433-AS1, which contains a unique glycophosphorylated site, may be a target for small molecules that can modulate protein-protein interactions.

Biomarker Potential

ZNF433-AS1 has also been identified as a potential biomarker for various diseases, including cancer. The regulation of ZNF433-AS1 has been shown to play a critical role in the development and progression of various diseases, including cancer. For example, studies have shown that ZNF433-AS1 is downregulated in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, the expression of ZNF433-AS1 has been shown to be associated with the poor prognosis of various types of cancer.

Conclusion

In conclusion, ZNF433-AS1 is a unique protein that has been shown to play a critical role in various cellular processes, including cell growth, differentiation, and survival. Its unique structure and function make it a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of ZNF433-AS1

Protein Name: ZNF433 And ZNF878 Antisense RNA 1

The "ZNF433-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF433-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563